Key result
Digital health technologies facilitate interventions for preventing and treating cardiometabolic diseases.
Why the study?
Cardiometabolic diseases contribute to huge disease burdens in the Western Pacific region, where digital health technologies are increasingly used to facilitate prevention and management.
How do digital health technologies impact the prevention and management of cardiometabolic diseases in the Western Pacific region?
How do digital health technologies impact the prevention and management of cardiometabolic diseases in the Western Pacific region?
Digital health technologies, including wearables and AI, facilitate early prevention, automated diagnosis, and clinical decision-support for cardiometabolic diseases in the Western Pacific region.
Answers are grounded in this paper and cite their sources.
Supports digital health exploration in cardiometabolic care; leaves open rigorous trials in Western Pacific populations.
Cardiometabolic diseases (CMDs) are the major types of non-communicable diseases, contributing to huge disease burdens in the Western Pacific region (WPR). The use of digital health (dHealth) technologies, such as wearable gadgets, mobile apps, and artificial intelligence (AI), facilitates interventions for CMDs prevention and treatment. Currently, most studies on dHealth and CMDs in WPR were conducted in a few high- and middle-income countries like Australia, China, Japan, the Republic of Korea, and New Zealand. Evidence indicated that dHealth services promoted early prevention by behavior interventions, and AI-based innovation brought automated diagnosis and clinical decision-support. dHealth brought facilitators for the doctor-patient interplay in the effectiveness, experience, and communication skills during healthcare services, with rapidly development during the pandemic of coronavirus disease 2019. In the future, the improvement of dHealth services in WPR needs to gain more policy support, enhance technology innovation and privacy protection, and perform cost-effectiveness research.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2023) conducted a review in Cardiometabolic diseases. Digital health (dHealth) technologies was evaluated. Digital health technologies, such as wearable gadgets, mobile apps, and artificial intelligence, facilitate interventions for the prevention and treatment of cardiometabolic diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: